Dietary carbohydrate source alters gene expression profile of intestinal epithelium in mice

Nutrition and Cancer

Volumn 61, Issue 1, 2009, Pages 146-155

  Wang, Bing ^a   Bobe, Gerd ^a   LaPres, John J ^b   Bourquin, Leslie D ^a  

^a Michigan State University   (United States)

^b Michigan State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; COMPLEMENTARY DNA; GLUCOSE; MESSENGER RNA; SOMATOMEDIN C; STARCH; SUCROSE;

ANIMAL EXPERIMENT; ARTICLE; C57BL 6 MOUSE; CANCER RISK; CARBOHYDRATE DIET; CARCINOGENESIS; CELL ADHESION; CELL CYCLE; CELL PROLIFERATION; COLON CANCER; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; INTESTINE EPITHELIUM; INTESTINE EPITHELIUM CELL; INTESTINE TUMOR; METABOLISM; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUGAR INTAKE; UPREGULATION;

ANIMALS; COLONIC NEOPLASMS; DIETARY CARBOHYDRATES; DIETARY SUCROSE; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENES, APC; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; INTESTINAL MUCOSA; MALE; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RANDOM ALLOCATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; STARCH;

MUS;

EID: 58149154362     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580802372617     Document Type: Article

References (34)

1. Tuyns AJ, Kaaks R, and Haelterman M: Colorectal cancer and the consumption of foods: a case-control study in Belgium. Nutr Cancer 11, 189-204, 1988.
2. La Vecchia C, Franceschi A, Dolora P, Bidoli E, and Barbone F: Refined sugar intake and the risk of colorectal cancer in humans. Int J Cancer 55, 386-389, 1993.
3. Bostick RM, Potter JD, Kushi LH, Sellers TA, Steinmetz KA, et al.: Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States). Cancer Causes Control 5, 38-52, 1994.
4. Centonze S, Boeing H, Leoci C, Guerra V, and Misciagna G: Dietary habits and colorectal cancer in a low risk area Results from a population-based case-control study in Southern Italy. Nutr Cancer 21, 233-246, 1994.
5. De Stefani E, Mendilaharsu M, and Deneo-Pellegrini H: Sucrose as a risk factor for cancer of the colon and rectum: a case-control study in Uruguay. Int J Cancer 75, 40-44, 1998.
6. Kristiansen E and Thorup IM: Influence of different diets on development of DMH-induced aberrant crypt foci and colon tumor incidence in Wistar rats. Nutr Cancer 23, 151-159, 1995.
7. Caderni G, Dolara P, Spagnesi T, Lucerni C, Bianchini F, et al.: Rats fed high starch diets have lower colonic proliferation and faecal bile acids than high sucrose-fed controls. J Nutr 123, 704-712, 1993.
8. Caderni G, Lancioni L, Luceri C, Giannini A, Lodovici M, et al.: Dietary sucrose and starch affect dysplastic characteristics in carcinogen-induced aberrant crypt foci in rat colon. Cancer Lett 114, 39-41, 1997.
9. Poulsen M, Molck AM, Thorup I, Breinholt V, and Meyer O: The influence of simple sugars and starch given during pre- or post-initiation on aberrant crypt foci in rat colon. Cancer Lett 167, 135-43, 2001.
10. Caderni G, Luceri C, Spagnesi MT, Giannini A, Biggeri A, et al.: Dietary carbohydrates modify azoxymethane-induced intestinal carcinogenesis in rats. J Nutr 124, 517-523, 1994.
11. Min mice by increasing insulin and IGF-I levels. Nutr Cancer 61, 81-93, 2009.
12. Foulstone E, Prince S, Zaccheo O, Burns JL, Harper J, et al.: Insulin-like growth factor ligands, receptors, and binding proteins in cancer. J Pathol 205, 145-153, 2005.
13. Su LK, Kinzler KW, Vogelstein B, Preisinger AC, Moser AR, et al.: Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256, 668-670, 1992.
14. Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, et al.: Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253, 665-669, 1991.
15. Fearon E and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61, 759-767, 1990.
16. Reeves PG, Nielsen FH, and Fahey GC: AIN-93 purified diets for laboratory rodents: final report of the American Institution of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123, 1939-1951, 1993.
17. Hegde P, Qi R, Abernathy R, Gay C, Dharap S, et al.: A concise guide to cDNA microarray analysis. Biotechniques 29, 548-562, 2000.
18. Tanaka TS, Jaradat SA, Lim MK, Kargul GJ, Wang X, et al.: Genome-wide expression profiling of mid-gestation placenta and embryo using a 15,000 mouse developmental cDNA microarray. Proc Natl Acad Sci USA 97, 9127-9132, 2000.
19. Yi M, Horon JD, Cohen HC, Hobbs HH, and Stephens RM: WholePathwayScope: a comprehensive pathway-based analysis tool for high-throughput data. BMC Bioinformatics 7, 30, 2006.
20. Scaglia N and Igal RA: Stearoyl-CoA desaturase is involved in the control of proliferation, anchorage-independent growth, and survival in human transformed cells. J Biol Chem 280, 25339-25349, 2005.
21. Wiedmer T, Zhao J, Li L, Zhou Q, Hevener A, et al.: Adiposity, dyslipidemia, and insulin resistance in mice with targeted deletion of phospholipid scramblase 3 (PLSCR3). Proc Natl Acad Sci USA 101, 13296-13301, 2004.
22. Lecuit T: Cell adhesion: sorting out cell mixing with echinoid? Curr Biol 15, R505-R507, 2005.
23. Curmi PA, Gavet O, Charbaut E, Ozon S, Lachkar-Colmerauer S, et al.: Stathmin and its phosphoprotein family: General properties, biochemical and functional interaction with tubulin. Cell Struct Funct 24, 345-357, 1999.
24. Bravo R: Synthesis of the nuclear protein cyclin (PCNA) and its relationship with DNA replication. Exp Cell Res 163, 287-293, 1986.
25. Ruzinova MB and Benezra R: Id proteins in development, cell cycle and cancer. Trends Cell Biol 13, 410-418, 2003.
26. Behrens P, Brinkmann U, and Wellmann A: CSE1L/CAS: its role in proliferation and apoptosis. Apoptosis 8, 39-44, 2003.
27. He XC, Zhang J, Tong WG, Tawfik O, Ross J, et al.: BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nat Genet 36, 1117-1121, 2004.
28. Dixon DA, Balch GC, Kedersha N, Anderson P, Zimmerman GA, et al.: Regulation of cyclooxygenase-2 expression by the translational silencer TIA-1. J Exp Med 198, 475-481, 2003.
29. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, et al.: Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107, 1183-1188, 1994.
30. Fürstenberger G and Senn HJ: Insulin-like growth factors and cancer. Lancet Oncol 3, 298-302, 2002.
31. Hassan AB and Howell JA: Insulin-like growth factor II supply modifies growth of intestinal adenoma in Apc(Min/+) mice. Cancer Res 60, 1070-1076, 2000.
32. Giovannucci E, Pollak MN, Platz EA, Willett WC, Stampfer MJ, et al.: A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev 9, 345-349, 2000.
33. Hong J, Zhang G, Dong F, and Rechler MM: Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells. J Biol Chem 277, 10489-10497, 2002.
34. Valentinis B, Bhala A, DeAngelis T, Baserga R, and Cohen P: The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol Endocrinol 9, 361-367, 1995.